ALTERNATIVE CANCER RESEARCH

Image description

ABOUT

US

A positive cancer diagnosis is always a difficult thing to hear, but there are a wide range of treatment options available. However, with so much information out there and large amounts of pressure to undergo chemotherapy or radiotherapy faced by many patients, it can be difficult to look at other options that may be available.


The Alternative Cancer Research website has been set up, in order to take a look at some of the complementary cancer treatments and alternative cancer treatments that are available to people. Being told that you have cancer is a very difficult and confusing time. Unfortunately for many of those who are given this diagnosis, they feel that the only option available to them is chemotherapy or radiotherapy.


The Alternative Cancer Research website aims to give such patients some extra information about the different types of cancer therapy available, so that they can make more informed decisions about their future.


However, we would like to remind you that we are not medical professionals and that all of the information that can be found on this website is for information purposes only.


Before undertaking any sort of treatment or making any dietary changes it is always advisable to speak to an appropriate health professional first.


COMPLEMENTARY THERAPIES

According to Cancer Research UK, up to 33% of those with cancer use some form of complementary cancer therapy at some point during their illness. In fact, with some sorts of cancer, such as breast cancer, the number of people using complementary cancer therapies is closer to 50%.

 

People who use complementary therapies often use them to feel better and to help them cope with having both treatment and the cancer itself. How a person feels can have a huge impact upon how they cope with cancer. This is why many complementary therapies focus upon reducing stress and improving patients’ levels of relaxation.

 

Some cancer patients find that having conventional cancer treatment can be quite impersonal and that they do not feel as though they have much say about what is going on. On the other hand, they feel that complementary therapies give them the opportunity to have greater control over their treatment and recovery. This may also result in the patient feeling that they are in better control of their emotions and feelings.

 

Many of the people using complementary therapies may also feel that they are non toxic and more natural than conventional treatments. However, it is important to make sure that any complementary therapy that is being used is safe and will not undermine any conventional treatments that are being used.


  

What is CV247

 

CV247 is a combination product comprising of Sodium Salicylate, Copper Gluconate, Manganese Gluconate and Ascorbic Acid (Vitamin C) taken in the form of two tablets. The product was conceived and initially developed by Mr John Carter, veterinary surgeon, who also advocated that in combination with the therapy a patient also followed an organic diet.

 

Mr Carter established the treatment regime after many years of study and empirical research starting in around 1976. The work began after a number of friends and associates as well as many companion animals had succumbed to the effects of cancer. Mr Carter’s hypothesis was that the increasing rate of cancer affecting the human and animal world could have an association with modern food manufacturing methods and the environment. His theory and treatment was aimed at stimulating the individual’s immune system so as to resist the development or progression of cancer. The effect of this theory was repeatedly tested in his Veterinary practice on a compassionate treatment basis. Mr Carter’s interest and the success with the animals he treated led to word of mouth recommendations to tend to other animals suffering from cancer.

 

CV247 was seen by pet owners to have a notable rate of success on their respective companion animals, and an anecdotal portfolio of satisfied dog owners was compiled. 

 

After the success that had been seen in animals the product was then trialled on humans. The validity of this treatment has been demonstrated in various studies.


There have been three formal studies of the use of CV247 as a cancer treatment for humans. The first of these was a Phase II study, where 37 patients with progressive malignancy were put under analysis by Dr Robert Thomas (Consultant Oncologist at Bedford Hospital and Addenbrokes Hospital). Dr Robert Thomas also undertook a study of 110 patients with progressive prostate cancer over three years. In addition to this, a Phase II study of 36 patients at a private clinic in Harrow, Middlesex was completed by Dr Ros Taylor (Hospice of St Francis, Berkhamstead). The studies on animals and humans have shown the anti-tumour effect of the treatment, as well as its beneficial effect on the patients’ quality of life. They also showed that the treatment has few side effects.


 

How does CV247 work?

 

The active ingredients contained within CV247 are: Sodium Salicylate, Vitamin C, Manganese Gluconate and Copper Gluconate.

 

 

Sodium Salicylate: Sodium Salicylate is a non-steroidal, anti-inflammatory drug (NSAID). Salicylates are known to produce an anti-inflammatory effect by directly blocking prostaladin synthesis, this inhibits the cyclooxygenase enzymes that are generated in response to the cell activation caused by tumour promoters. There is currently a lot of interest regarding the use of NSAIDs as chemotheraputic agents.

 

Sodium salicylate works in a similar manner to aspirin, as such it has the same therapeutic benefits as aspirin, but with reduced adverse gastrointestinal effects.There have been a number of studies showing the benefits of aspirin when fighting cancer, including a study by Professor Peter Rothwell (Oxford University’s Stroke Prevention Unit) that has suggested that low-dose daily aspirin could not only stop cancers from developing in the first place, but could also prevent its spread to other parts of the body. This gives the use of sodium salicylate as a key component in CV247 an interesting scientific backing.

 

 

Vitamin C: Vitamin C (asorbic acid) is regarded as one of the most important anti-oxidants for mammals. As a result, asorbic acid is the most commonly used single nutrient supplement amongst cancer patients. Vitamin C forms an integral part of the body’s anti-oxidant defences against free radicals and oxygen reactive species.

 

Vitamin C (ascorbic acid) has long been viewed as one of the most essential vitamins in order to maintain good health. After all it protects the cells within the body and keeps them healthy. In addition to this, it also helps to maintain healthy connective tissue, which gives support for other tissue and organs. It therefore should come as no surprise that it has been considered as a possible cancer treatment, which has become increasingly popular amongst those seeking complementary or alternative therapies. See our OTHER THERAPIES page for more details about Vitamin C use in cancer therapy.

 

 

Manganese Gluconate: Manganese is an essential element for the body to maintain normal brain function and helps to create several different enzymatic reactions. It is also an important part of the body’s defense mechanism against reactive oxygen species. Altered amounts of manganese within the body have also been implicated in multistage carcinogenesis (the creation of cancer cells) in both humans and rodents.

 

 

Copper Gluconate: Copper can adopt distinct states that allow it to play a crucial role in the eradication of free radicals. Copper is also a co-factor in a number of enzymes that help to fight oxidative stress. A copper deficiency could increase the risk of oxidative DNA damage within the body.

 

 

CV247 in the news

CV247 has had a number of positive news articles featured about it over the years. Here are some of those.

ITV News: 21st November 2014 Dog makes miraculous recovery from tumour http://www.itv.com/news/meridian/2014-11-21/dog-makes-miraculous-recovery-from-tumour/


BBC News: 27th March 2001 Vet's drug fights human cancers http://news.bbc.co.uk/1/hi/health/1245530.stm

Daily Mail: The new cancer treatment that's thanks to a vet! - http://www.dailymail.co.uk/health/article-35508/The-new-cancer-treatment-thats-thanks-vet.html

Mail On Sunday: 31 January 2010 Fred Portch was given a year to live...a decade later his cancer is all gone. All he took was CV247

Image description

CV247 Videos

How to get CV247

CV247 can only be prescribed as an unlicensed special by a doctor, on a named patient basis, within the United Kingdom. This is because it does not hold marketing authorisation yet within the UK. It is often prescribed as an alternative to palliative treatment, However, CV247 can also be prescribed as an adjuvent to chemotherapy, radiotherapy and surgery. CV247 can only be prescribed for an individual where no similar medication is available and only when the prescribing doctor feels that it would be beneficial.

 

For more information regarding CV247, visit http://www.cvpharma.co.uk